Lexicon Pharma: Inpefa's Early Clinical Benefits, Rehospitalization Data May Unlock Significant ValueSeeking Alpha • 01/04/24
Lexicon Pharmaceuticals To Participate In The 42nd Annual JPMorgan Healthcare ConferenceGlobeNewsWire • 12/21/23
Lexicon Enrolls First Patient in Phase 2b Progress Study of LX9211 in Diabetic Peripheral Neuropathic Pain (DPNP)GlobeNewsWire • 11/30/23
Lexicon Pharmaceuticals to Participate in the 35th Annual Piper Sandler Healthcare Conference and the 6th Annual Evercore ISI HealthCONx ConferenceGlobeNewsWire • 11/22/23
INPEFA® (sotagliflozin) Use Associated With Early Clinical Benefit in Heart Failure and Atherosclerotic Events in Analysis of Clinical DataGlobeNewsWire • 11/12/23
Lexicon Pharmaceuticals to Participate in the Jefferies London Healthcare ConferenceGlobeNewsWire • 11/10/23
Lexicon Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business UpdateGlobeNewsWire • 11/08/23
Lexicon Pharmaceuticals to Host Third Quarter 2023 Financial Results Conference Call and Webcast on November 8, 2023GlobeNewsWire • 11/03/23
Data on Early Clinical Benefit for INPEFA® (Sotagliflozin) Will Be Among Five Lexicon-Sponsored Presentations at the American Heart Association Scientific Sessions 2023GlobeNewsWire • 11/02/23
INPEFA® (Sotagliflozin) Receives Coverage From Express Scripts on Its Basic and High Performance Formularies for Commercially Insured PatientsGlobeNewsWire • 11/01/23
New Data Relating to Sotagliflozin to be Presented at the American Society of Nephrology (ASN) Kidney Week 2023 Annual MeetingGlobeNewsWire • 10/30/23
Data From Two Studies Demonstrating Positive Financial Impact of INPEFA® (Sotagliflozin) to be Presented at the Academy of Managed Care Pharmacy (AMCP) Nexus 2023 National MeetingGlobeNewsWire • 10/17/23
Data Demonstrating Financial Impact of INPEFA® (Sotagliflozin) to be Presented at the Academy of Managed Care Pharmacy (AMCP) Nexus 2023 National MeetingGlobeNewsWire • 10/11/23
Lexicon Pharmaceuticals shares rise on Express Scripts support for Inpefa heart drugProactive Investors • 10/10/23
INPEFA® (Sotagliflozin) Receives Preferred Formulary Status With Express Scripts For Medicare PatientsGlobeNewsWire • 10/09/23
Tom Garner Joins Lexicon as Senior Vice President and Chief Commercial OfficerGlobeNewsWire • 10/09/23
Lexicon to Present Post Hoc Analysis of Scored Clinical Trial at the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2023GlobeNewsWire • 09/28/23
Lexicon Pharmaceuticals to Participate in the H.C. Wainwright & Co. 25th Annual Global Investment ConferenceGlobeNewsWire • 09/07/23